Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue British Journal of Haematology Année : 2018

Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease

(1) , (2) , (3) , (4) , (5) , (2)
1
2
3
4
5

Dates et versions

hal-03605027 , version 1 (10-03-2022)

Identifiants

Citer

Deborah Assouan, Delphine Lebon, Amandine Charbonnier, Bruno Royer, Jean-Pierre Marolleau, et al.. Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease. British Journal of Haematology, 2018, 181 (5), pp.687-689. ⟨10.1111/bjh.14679⟩. ⟨hal-03605027⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More